Cano Health Inc. Class A (CANO) Financials

$0.24

$-0.03 (-9.62%)

As on 05-Apr-2024 09:30EDT

Market cap

$12 Mln

Revenue (TTM)

$3,102 Mln

P/E Ratio

--

P/B Ratio

1.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	3,102.10	2,738.92	1,609.37	831.58	361.38	--
Cost of Revenue	2,948.99	2,317.22	1,410.40	666.35	284.67	--
Gross Profit	153.12	421.69	198.97	165.23	76.71	--
Operating Expenses	554.17	513.08	301.57	122.46	65.97	--
Operating Profit (EBIT)	-772.51	-89.67	-102.61	42.64	10.81	--
Other Income	84.45	73.06	69.76	-22.86	--	--
Profit before Tax	-1,125.25	-426.23	-116.72	-70.41	-19.78	--
Provision for Tax	-32.94	2.16	0.01	0.65	9.91	--
Profit after Tax (Net Income)	-731.12	-428.39	-116.74	-71.06	-29.69	--
Minority Interest	-84.58	-221.12	-98.72	--	0.39	0.49
Consolidated Profit	-577.76	-207.27	-18.02	-28.88	-19.78	-8.51

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-122.10	255.01	318.73	49.63	98.07	--
Minority Interest	-84.58	241.64	479.84	--	--	--
Non-Current Liabilities	1,105.10	1,226.21	1,183.94	497.39	132.95	--
Current Liabilities	365.93	208.44	161.04	67.18	86.15	11.64
Total Liabilities	1,577.87	1,928.93	2,143.54	614.19	326.08	--

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	1,067.21	1,588.18	1,826.30	503.17	236.86	--
Current Assets	144.72	340.75	317.24	111.02	82.88	32.02
Total Assets	1,577.87	1,928.93	2,143.54	614.19	0.05	--
Total Debt*	1,241.40	1,199.72	1,065.28	465.19	--	--
Net Current Assets	-221.21	132.31	156.20	43.84	--	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-146.34	-128.53	-9.24	-15.47	-6.70
Cash Flow from Investing Activities	--	-64.16	-1,131.25	-690.00	-90.78	-24.30
Cash from Financing Activities	--	74.65	1,389.14	282.22	132.04	28.87
Net Cash Inflow / Outflow	--	-135.84	129.36	1.04	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-248.71	-176.88	-65.71	-0.43	--	--
Cash EPS ($)	--	-139.46	-37.88	-0.31	--	--
Adjusted Book Value ($)	--	105.29	179.42	0.30	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-60.42	-72.35	-0.06	--	--
Free Cash Flow per Share ($)	--	-80.87	-91.69	-0.13	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-30.18	-12.30	-23.19	-60.55	--
ROE (%)	--	-149.33	-63.38	-96.23	-30.28	--
ROA (%)	-36.93	-21.04	-8.47	-15.12	-9.11	--
EBIT Margin (%)	-12.88	-3.27	-6.38	5.13	2.99	--
Net Margin (%)	-22.94	-15.23	-6.95	-8.79	-8.22	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	21.60	0.70	0.94	1.30	--	--
EBIT Growth (%)	-279.38	12.61	-340.63	294.41	16.67	--
Net Profit Growth (%)	-254.03	-266.97	-64.27	-139.33	--	--
EPS Growth (%)	-388.33	-1.69	-153.55	--	--	--
Book Value Growth (%)	-124.61	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.01	-0.14	-31.54	--	--
Price / Book Value	1.55	0.01	0.05	45.16	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.31	1,212.07	-17.25	32.42	--	--
Close Price ($)	25.40	137.00	891.00	1,341.00	--	--
High Price ($)	975.00	975.00	1,743.00	1,470.00	--	--
Low Price ($)	22.00	98.00	787.00	500.00	--	--
Market Cap ($ Cr)	12.43	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	-7.79	4.70	3.34	9.37	--	--
Short term debt to equity ratio	-1.17	0.13	0.07	0.12	--	--
Current Ratio	0.40	1.63	1.97	1.65	0.96	2.75
Quick Ratio	0.40	1.63	1.96	1.64	0.95	2.73
Interest Coverage	-10.31	-1.43	-2.00	1.25	1.06	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	2.82	8.54	8.29	8.10	13.63	--
Asset Turnover	1.57	1.35	1.17	1.77	1.11	--
Receivable days	--	24.49	22.78	25.61	38.61	--
Inventory Days	--	0.09	0.26	0.43	0.59	--
Payable days	--	14.07	13.48	12.06	12.39	--
Cash Conversion Cycle	--	10.51	9.56	13.98	26.81	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.